Epacria Capital Partners’s Calumet Specialty Products CLMT Stock Holding History

Epacria Capital Partners’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-76,037	Closed	-$1.22M	–	53
2024 Q2	$1.22M	Sell	76,037 -1,454	-2%	-$23K	0.89%	30
2024 Q1	$1.15M	Hold	77,491	–	–	0.83%	31
2023 Q4	$1.38M	Hold	77,491	–	–	1.11%	25
2023 Q3	$1.48M	Buy	77,491 +176	+0.2%	+$3.05K	1.23%	24
2023 Q2	$1.23M	Buy	77,315 +2,909	+4%	+$47.9K	1%	27
2023 Q1	$1.29M	Buy	74,406 +20,401	+38%	+$362K	1%	27
2022 Q4	$912K	Buy	+54,005	New	+$871K	0.72%	34

Other funds holding CLMT

WDOM

Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

DMKJ

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCM

Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Epacria Capital Partners's CLMT Position: Q3 2024 in Review

Epacria Capital Partners sold out of Calumet Specialty Products (CLMT) in Q3 2024, closing a stake of 76,037 shares — an estimated $1.22M sold.

Epacria Capital Partners first reported a position in CLMT in Q4 2022 and held it in 7 quarters. The position peaked at $1.48M in Q3 2023. 91 funds tracked by Wall St. Rank hold CLMT as of Q3 2024.

Epacria Capital Partners reported no remaining Calumet Specialty Products position as of Q3 2024 after selling out during the quarter.
Epacria Capital Partners sold 76,037 Calumet Specialty Products shares in Q3 2024, an estimated $1.22M.
Epacria Capital Partners first reported a position in Calumet Specialty Products in Q4 2022 and held it in 7 quarters.
Epacria Capital Partners's Calumet Specialty Products position peaked at $1.48M in Q3 2023.
91 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2024.

Based on Epacria Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.